Biotech · Private company
Dr. Falk Pharma GmbH
Track this companyFree. Adds Dr. Falk Pharma GmbH to your Dealase workspace and tells you when its record changes.
Clinical trials31 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- BudesonidePhase 3 · Eosinophilic EsophagitisClinicalTrials.gov · fetched Nov 12, 2026
- NaronapridePhase 2 · GastroparesisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Different Doses of Naronapride vs. Placebo in GastroparesisPHASE2 · COMPLETED · started Jan 3, 2023ClinicalTrials.gov NCT05621811 · fetched Nov 12, 2026
- Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoEPHASE3 · ACTIVE_NOT_RECRUITING · started May 21, 2021ClinicalTrials.gov NCT06596252 · fetched Nov 12, 2026
- A Study Evaluating the Efficacy and Safety of ST-0529 in Subjects With Moderately to Severely Active Ulcerative ColitisPHASE2 · TERMINATED · started Jan 24, 2019ClinicalTrials.gov NCT03844932 · fetched Nov 12, 2026